A new study has found that FAPI PET/CT is more effective than FDG in predicting progressive pulmonary fibrosis in ILD patients. The study's results suggest that FAPI PET/CT can identify high-risk patients who require closer monitoring or preventive treatment.
Researchers have developed a method to synthesize an organotin mercaptide-based thermal stabilizer from palm fatty acid distillate, offering a competitive alternative to existing PVC stabilizers. The synthesized material demonstrates superior thermal stability at lower dosages and is economically viable.
A study analyzing pooled clinical trial data found that teprotumumab maintained improvements in signs and symptoms of thyroid eye disease in most patients after 51 weeks. Nearly two years after the final infusion, 82% of patients did not require further treatment.
The new law recognizes personalized medicine as a fundamental patient right, emphasizing individualized treatment and care. It sets a precedent for future health care innovations worldwide, integrating genomics, proteomics, and AI technologies.
Researchers found that FAP-targeted radioligand therapy controlled disease progression in nearly half of patients with advanced sarcoma, and was well-tolerated without critical organ radiation dose levels being reached. The study's results indicate a promising approach for this patient group with limited treatment options.